Skip to main content

Kill Cancer In 42 Days

Cancer is abnormal,uncontrollable growth  of cells.Many people spend their whole lives to find some solution for cancer. Some of them just wasted their lives, but some of them are almost at the end.

Rudolf Brojs is the person who made a special drink which is extremely effective in the treatment of cancer. His amazing beverage has cured over 45 000 people who has suffered from cancer. According to his opinion, the consumption of protein can treat this disease.

The treatment of this person lasts for 45 days. Rudolf recommends only consuming his juice and tea. You will improve your overall health, starve and kill the cancer cells during these 42 day.

How to prepare juice?

Ingredients:

Radishes-2%
Potatoes-3%
Celery Root-20%
Carrots-20%
Beetroot-55%

You only have to place all the ingredients in a blender (juicer) and mix well.

Do not forget that you should consume this juice as your body requires, do not overdo with the consumption of the beverage.

How it works?Beets are full of betaine – extremely powerful detoxification, antioxidant and anti-inflammatory agent. This amino acid is rich in strong anti-cancer properties. Many studies have shown that this acid eliminates cells in the tumor tissue.

The presence of folic acid in this beverage makes it useful for pregnant women. It prevents constipation and boosts the function of the gall bladder and the liver. It also helps with menstrual pain, skin issues, bone problems, dysentery, toothaches, toothaches and headaches. This all purpose plant should be implemented into your everyday diet.

Comments

Popular posts from this blog

A Blood Test That Detects Early Alzheimer’s disease

A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy. In a “proof of concept” study involving 236 subjects, the test demonstrated an overall accuracy, sensitivity and specificity rate of 100 percent in identifying subjects whose MCI was actually caused by an early stage of Alzheimer’s disease. “About 60 percent of all MCI patients have MCI caused by an early stage of Alzheimer’s disease. The remaining 40 percent of cases are caused by other factors, including vascular issues, drug side-effects and depression. To provide proper care, physicians need to know which cases of MCI are due to early Alzheimer’s and which are not,” ...

The New Blood Group 'INRA'

Usually there are 4 or 5 blood groups to be known namely A,B,O,AB and rarely Bombay or HH blood group. The Bombay blood group are named after its discovery in the city Bombay (now called Mumbai city)discover by the Dr. Y.M. Bhende in 1952  and this is the first time India become a parent of the new and rarest type of blood group. It is obvious,Bomby blood group is the first blood group found in India but not the least "because discovery never stops" This saying fix here perfectly,A person with new & rare blood group is found in Lok Samparn Raktdan laboratory, Surat, Gujarat. The person’s blood group doesn’t match with any other A, B, O, AB and also Bombay Blood Group or also called as HH Blood Group. The new blood group is named as INRA; the first 2 letters represent India (IN) & the next two name of the person (RA). INRA blood group is identified for the first time when the person visited for donating blood in Blood Camp. The blood sample...

Artificial Cancer-Killing Virus

It is the genome of an oncolytic virus, it is 34,000 base pairs long, and it is 100% artificial. It’s important because it not only has immediate application in studies of canine cancer, it also promises to inform the development of human therapies. In these human therapies, artificial viruses could be customized to such an extent, that they could qualify as personalized anticancer therapeutics.  It is not the first time that oncolytic viruses has engineered but earlier virus like Herpes simplex and Oncorine(H101) are also being used.  The virus in question in sCAV2, a conditionally replicative adenovirus (CRAd) that can target and kill tumor cells while sparing healthy cells. It was synthesized by scientists affiliated with Gen9, who worked in concert with scientists representing Autodesk and Auburn University. At Auburn, scientists led by Bruce Smith, V.M.D., Ph.D., intend to use the synthetic virus to evaluate therapeutic treatments in dogs with osteosa...